Showing results (21-30 of 544) with videos related to
Sort By:
Pageof 55
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in acute coronary syndromeIngo Ahrens, Christoph BodeFuture Cardiology|August 9, 2012
Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndromeIngo Ahrens, Christoph BodeEuropean Journal of Preventive Cardiology|June 2, 2011
Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registryAnselm K Gitt, Peter Bramlage, Christiane Binz, et al.Cardiovascular Diabetology|March 21, 2013
Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy--an analysis of the DiaRegis registryJürgen Wasem, Peter Bramlage, Anselm K Gitt, et al.Cardiovascular Diabetology|September 17, 2010
Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baselinePeter Bramlage, Christiane Binz, Anselm K Gitt, et al.Cardiovascular Diabetology|July 16, 2011
Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registryDiethelm Tschöpe, Peter Bramlage, Christiane Binz, et al.Diabetes Care|October 25, 2018
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week StudyParesh Dandona, Chantal Mathieu, Moshe Phillip, et al.Expert Review of Cardiovascular Therapy|September 11, 2010
Clopidogrel in acute coronary syndrome: implications of recent study findingsDaniel Duerschmied, Christoph Bode, Martin MoserHerz|April 2, 2004
Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studiesJoachim Schofer, Christoph Bode, Sigmund SilberTherapeutics and Clinical Risk Management|September 9, 2015
Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosisPhilipp Diehl, Christoph Bode, Daniel DuerschmiedPageof 55